
Relief Therapeutics and NeuroX to combine in new company
Biotechnology company Relief Therapeutics has announced a business combination with commercial-stage company NeuroX to create a new digital neurotherapeutics company. The business combination follows approval from Relief’s shareholders, who have also approved a capital increase through the issuance of 140 million new ordinary shares. The business combination is expected to close in December… Read More















